p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer
Miller P. et al, (2023), Cell Death & Differentiation, 30, 1619 - 1635
Regulation of immunological tolerance by the p53-inhibitor iASPP
Akama-Garren EH. et al, (2023), Cell Death & Disease, 14
Mutant Ras and inflammation-driven skin tumorigenesis is suppressed via a JNK-iASPP-AP1 axis
Al Moussawi K. et al, (2022), Cell Reports, 41, 111503 - 111503
Ciliogenesis and Hedgehog signalling are supressed downstream of KRas during acinar-ductal metaplasia
Bangs FK. et al, (2020), Disease Models & Mechanisms
Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells
Wang Y. et al, (2019), Autophagy, 15, 886 - 899
An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells
Freedman JD. et al, (2018), Cancer Research, 78, 6852 - 6865
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
Freedman JD. et al, (2017), EMBO Molecular Medicine, 9, 1067 - 1087
ASPP2 deficiency causes features of 1q41q42 microdeletion syndrome
Zak J. et al, (2016), Cell Death & Differentiation, 23, 1973 - 1984
Restoring the tumour suppressive function of p53 as a parallel strategy in melanoma therapy
Lu M. et al, (2014), FEBS Letters, 588, 2616 - 2621
Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome
Lalezari S. et al, (2013), Neuro-Oncology, 15, 370 - 381
Quantitative evaluation of white matter tract DTI parameter changes in gliomas using nonlinear registration
Miller P. et al, (2012), NeuroImage, 60, 2309 - 2315